اشترك بالحزمة الذهبية واحصل على وصول غير محدود شمرا أكاديميا
تسجيل مستخدم جديدRaman-assisted crystallography reveals end-on peroxide intermediates in a nonheme iron enzyme
46
0
0.0
(
0
)
تأليف
Gergely Katona
اسأل ChatGPT حول البحث
ﻻ يوجد ملخص باللغة العربية
Iron-peroxide intermediates are central in the reaction cycle of many iron-containing biomolecules. We trapped iron(III)-(hydro)peroxo species in crystals of superoxide reductase (SOR), a nonheme mononuclear iron enzyme that scavenges superoxide radicals. X-ray diffraction data at 1.95 angstrom resolution and Raman spectra recorded in crystallo revealed iron-(hydro)peroxo intermediates with the (hydro)peroxo group bound end-on. The dynamic SOR active site promotes the formation of transient hydrogen bond networks, which presumably assist the cleavage of the iron-oxygen bond in order to release the reaction product, hydrogen peroxide.
قيم البحث
اقرأ أيضاً
Three-dimensional RNA models fitted into crystallographic density maps exhibit pervasive conformational ambiguities, geometric errors and steric clashes. To address these problems, we present enumerative real-space refinement assisted by electron den
sity under Rosetta (ERRASER), coupled to Python-based hierarchical environment for integrated xtallography (PHENIX) diffraction-based refinement. On 24 data sets, ERRASER automatically corrects the majority of MolProbity-assessed errors, improves the average Rfree factor, resolves functionally important discrepancies in noncanonical structure and refines low-resolution models to better match higher-resolution models.
Biocatalysis is a promising approach to sustainably synthesize pharmaceuticals, complex natural products, and commodity chemicals at scale. However, the adoption of biocatalysis is limited by our ability to select enzymes that will catalyze their nat
ural chemical transformation on non-natural substrates. While machine learning and in silico directed evolution are well-posed for this predictive modeling challenge, efforts to date have primarily aimed to increase activity against a single known substrate, rather than to identify enzymes capable of acting on new substrates of interest. To address this need, we curate 6 different high-quality enzyme family screens from the literature that each measure multiple enzymes against multiple substrates. We compare machine learning-based compound-protein interaction (CPI) modeling approaches from the literature used for predicting drug-target interactions. Surprisingly, comparing these interaction-based models against collections of independent (single task) enzyme-only or substrate-only models reveals that current CPI approaches are incapable of learning interactions between compounds and proteins in the current family level data regime. We further validate this observation by demonstrating that our no-interaction baseline can outperform CPI-based models from the literature used to guide the discovery of kinase inhibitors. Given the high performance of non-interaction based models, we introduce a new structure-based strategy for pooling residue representations across a protein sequence. Altogether, this work motivates a principled path forward in order to build and evaluate meaningful predictive models for biocatalysis and other drug discovery applications.
The output of molecular dynamics simulations is high-dimensional, and the degrees of freedom among the atoms are related in intricate ways. Therefore, a variety of analysis frameworks have been introduced in order to distill complex motions into lowe
r-dimensional representations that model the system dynamics. These dynamical models have been developed to optimally approximate the systems global kinetics. However, the separate aims of optimizing global kinetics and modeling a process of interest diverge when the process of interest is not the slowest process in the system. Here, we introduce deflation into state-of-the-art methods in molecular kinetics in order to preserve the use of variational optimization tools when the slowest dynamical mode is not the same as the one we seek to model and understand. First, we showcase deflation for a simple toy system and introduce the deflated variational approach to Markov processes (dVAMP). Using dVAMP, we show that nondominant reaction coordinates produced using deflation are more informative than their counterparts generated without deflation. Then, we examine a protein folding system in which the slowest dynamical mode is not folding. Following a dVAMP analysis, we show that deflation can be used to obscure this undesired slow process from a kinetic model, in this case a VAMPnet. The incorporation of deflation into current methods opens the door for enhanced sampling strategies and more flexible, targeted model building.
We demonstrate that a common-line method can assemble a 3D oversampled diffracted intensity distribution suitable for high-resolution structure solution from a set of measured 2D diffraction patterns, as proposed in experiments with an X-ray free ele
ctron laser (XFEL) (Neutze {it et al.}, 2000). Even for a flat Ewald sphere, we show how the ambiguities due to Friedels Law may be overcome. The method breaks down for photon counts below about 10 per detector pixel, almost 3 orders of magnitude higher than expected for scattering by a 500 kDa protein with an XFEL beam focused to a 0.1 micron diameter spot. Even if 10**3 orientationally similar diffraction patterns could be identified and added to reach the requisite photon count per pixel, the need for about 10**6 orientational classes for high-resolution structure determination suggests that about ~ 10**9 diffraction patterns must be recorded. Assuming pulse and read-out rates of 100 Hz, such measurements would require ~ 10**7 seconds, i.e. several months of continuous beam time.
A recent experimental study found that the binding affinity between the cellular receptor human angiotensin converting enzyme 2 (ACE2) and receptor-binding domain (RBD) in spike (S) protein of novel severe acute respiratory syndrome coronavirus 2 (SA
RS-CoV-2) is more than 10-fold higher than that of the original severe acute respiratory syndrome coronavirus (SARS-CoV). However, main-chain structures of the SARS-CoV-2 RBD are almost the same with that of the SARS-CoV RBD. Understanding physical mechanism responsible for the outstanding affinity between the SARS-CoV-2 S and ACE2 is the urgent challenge for developing blockers, vaccines and therapeutic antibodies against the coronavirus disease 2019 (COVID-19) pandemic. Considering the mechanisms of hydrophobic interaction, hydration shell, surface tension, and the shielding effect of water molecules, this study reveals a hydrophobic-interaction-based mechanism by means of which SARS-CoV-2 S and ACE2 bind together in an aqueous environment. The hydrophobic interaction between the SARS-CoV-2 S and ACE2 protein is found to be significantly greater than that between SARS-CoV S and ACE2. At the docking site, the hydrophobic portions of the hydrophilic side chains of SARS-CoV-2 S are found to be involved in the hydrophobic interaction between SARS-CoV-2 S and ACE2. We propose a method to design live attenuated viruses by mutating several key amino acid residues of the spike protein to decrease the hydrophobic surface areas at the docking site. Mutation of a small amount of residues can greatly reduce the hydrophobic binding of the coronavirus to the receptor, which may be significant reduce infectivity and transmissibility of the virus.
سجل دخول لتتمكن من نشر تعليقات
التعليقات
جاري جلب التعليقات
سجل دخول لتتمكن من متابعة معايير البحث التي قمت باختيارها
